Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)

NCT01701479 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
288
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

St. Anna Kinderkrebsforschung

Collaborators